Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

Share Price is delayed by 15 minutes
Get Live Data
152.80    -0.20 (-0.13%)
Bid:
153.20
Ask:
153.60
Spread: 0.40 (0.261%)
Market Cap: £874.50m
ELM Live PriceLast checked at - London Stock Exchange

Intraday Elementis Share Chart

Directorate change

19 Mar 2026 07:00

RNS Number : 2295X
Elementis PLC
19 March 2026
 

 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 of 16 April 2014 which forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

Appointment of Non-Executive Chair and Non-Executive Director

 

Elementis plc ("Elementis" or the "Group") is pleased to announce the appointment of Trudy Schoolenberg as Non-Executive Chair with effect from the end of the Annual General Meeting on 29 April 2026. Trudy will succeed John O'Higgins who announced in October 2026 that he would not stand for re-election.

Trudy has served as Non-Executive Senior Independent Director of Elementis since April 2022. She has around 35 years' experience in the chemicals, engineering and high‑performance product sectors, including ten years as a Senior Independent Director. Trudy also serves as Chair of Accsys Technologies PLC. Trudy's deep experience means she is exceptionally well placed to lead the Board of Elementis as it enters its next phase of growth. Trudy will continue as a member of the Remuneration Committee and will chair the Nomination Committee.

Christine Soden, Non-Executive Director, will be appointed as interim Senior Independent Director. Christine will continue in her current committee roles.

Elementis is also pleased to announce the appointment of Mike Humphrey as an Independent Non-Executive Director with effect from 29 April 2026, the date of its forthcoming AGM. Mike will bring significant leadership and operational experience in the specialty chemicals sector, having been Chief Executive Officer of Croda International plc from 1999 to 2011, playing a crucial role in reshaping its strategic focus on specialty markets. During Mike's tenure, Croda developed into a focused, innovation-led business with strong margins, global reach and a premium market positioning.

Trudy Schoolenberg, Chair designate and Non-Executive Director, said:

"I am delighted to be appointed Chair and look forward to working with Mike and the rest of the Board to support Luc van Ravenstein and the Leadership Team as they deliver our Elevate Elementis strategy."

Luc van Ravenstein, CEO, said:

"I would like to congratulate Trudy on her appointment as Chair. Her broad international experience, deep knowledge of the industry and respected position within Elementis make her the right leader at this important juncture for the business. I am also very pleased to welcome Mike, whose expertise will bring additional strength and depth to the Board."

There are no further disclosures required in respect of this announcement under UKLR.6.4.8.

The person responsible for the release of this announcement on behalf of Elementis plc is Hannah Constantine, Group General Counsel and Company Secretary.

Enquiries

Investors:

Hannah Constantine, Group General Counsel & Company Secretary, Elementis plc

Tel: +44 (0) 20 8148 5966

Zeeshan Maqbool, Investor Relations, Elementis plc

Tel: +44 (0) 7553 340 380

Press:

Martin Robinson/Giles Kernick, Teneo

Tel: +44 (0) 20 7353 4200

 

 

LEI: 549300LQIH685LI2ML36 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUWRORNRUOAUR
Date   Source Headline
8th Jun 20265:14 pmRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSCommencement of share buyback programme
2nd Jun 20267:00 amRNSSale of Pharma business & intended buyback launch
1st Jun 20269:58 amRNSTotal Voting Rights
5th May 20265:26 pmRNSHolding(s) in Company
1st May 20269:59 amRNSTotal Voting Rights
29th Apr 20263:47 pmRNSResult of AGM
29th Apr 20267:00 amRNSFirst quarter trading update
8th Apr 20264:14 pmRNSDirector/PDMR Shareholding
7th Apr 20263:06 pmRNSDirector/PDMR Shareholding
1st Apr 202610:18 amRNSTotal Voting Rights
30th Mar 20265:06 pmRNSCorrection - Admission to Trading
30th Mar 20261:58 pmRNSAdmission to Trading
26th Mar 202612:09 pmRNSNotice of AGM and Annual Report & Accounts
19th Mar 20267:00 amRNSDirectorate change
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
11th Mar 20263:18 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:40 pmRNSDirector/PDMR Shareholding
10th Mar 20263:39 pmRNSDirector/PDMR Shareholding
9th Mar 20265:14 pmRNSHolding(s) in Company
5th Mar 20265:11 pmRNSBlocklisting Interim Review
5th Mar 20264:57 pmRNSPreliminary Results - Correction
5th Mar 20267:00 amRNSPreliminary Results
2nd Mar 202610:00 amRNSTotal Voting Rights
25th Feb 20264:22 pmRNSDirectorate change
2nd Feb 202610:05 amRNSTotal Voting Rights
21st Jan 20267:00 amRNSTrading Update
2nd Jan 202611:10 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSConfirmation of Board changes
2nd Jan 20267:00 amRNSConfirmation of Board changes
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
24th Dec 202510:25 amRNSDirector/PDMR Shareholding
15th Dec 20257:00 amRNSCompletion of Buyback programme
15th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20255:35 pmRNSTransaction in Own Shares
10th Dec 20256:12 pmRNSTransaction in Own Shares
9th Dec 20255:55 pmRNSTransaction in Own Shares
8th Dec 20255:52 pmRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20256:06 pmRNSTransaction in Own Shares
3rd Dec 20255:28 pmRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20255:49 pmRNSTransaction in Own Shares
28th Nov 20255:49 pmRNSTransaction in Own Shares
27th Nov 20255:40 pmRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSElementis acquires personal care specialist
25th Nov 20255:44 pmRNSTransaction in Own Shares
24th Nov 20256:01 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.